Completed
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
NCT00060684
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
- Locations
-
- Arizona Clinical Research Center Tucson, Arizona, United States
- Greater Baltimore Medical Center Baltimore, Maryland, United States
- New Mexico Onc/Hem Consultants, Inc. Albuquerque, New Mexico, United States
- MD Anderson Cancer Center Houston, Texas, United States